Bayer Pays $1.6B To Resolve 90% Of 39,000 U.S. Essure Claims

Bayer (BAYRY) announced that it has reached agreements with plaintiff law firms to resolve approximately 90% of the nearly 39,000 total filed and unfiled U.S. Essure claims involving women who allege device-related injuries.

The settlements include all of the jurisdictions with significant volumes of Essure cases, including the state of California Joint Council Coordinated Proceedings and Federal District Court for the Eastern District of Pennsylvania, the company said in a statement. Bayer will pay approximately $1.6B to resolve these claims, including an allowance for outstanding claims, and is in resolution discussions with counsel for the remaining plaintiffs.

Settling claimants will be required to dismiss their cases or not file. There is no admission of wrongdoing or liability by Bayer in the settlement agreements. The other terms of the settlement agreements are confidential. The settlement amount is covered by existing provisions, Bayer added.

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.